Showing results (251-260 of 443) with videos related to
Sort By:
Pageof 45
Giornale Italiano Di Cardiologia (2006)|June 25, 2026
[Ranolazine: established indications and emerging therapeutic potential]Stefania Angela Di Fusco, Luigi Pollarolo, Antonella Spinelli, et al.Journal of Cardiovascular Pharmacology and Therapeutics|August 8, 2020
Prevalence and Predictors of Out-of-Target LDL Cholesterol 1 to 3 Years After Myocardial Infarction. A Subanalysis From the EYESHOT Post-MI RegistryAngelo Silverio, Rossella Maria Benvenga, Federico Piscione, et al.JACC. Advances|August 12, 2024
Characteristics and Management of Patients With Cancer and Atrial Fibrillation: The BLITZ-AF Cancer RegistryMichele Massimo Gulizia, Fabio Maria Turazza, Pietro Ameri, et al.Giornale Italiano Di Cardiologia (2006)|November 26, 2024
[ANMCO Statement: semaglutide in cardio-nephro-metabolic disorders]Leonardo De Luca, Claudio Bilato, Alessandro Navazio, et al.Giornale Italiano Di Cardiologia (2006)|May 27, 2026
[Gender bias and artificial intelligence in cardiology: evidence, clinical implications, and future perspectives]Maria Teresa Manes, Giuseppe Ciliberti, Antonia Mannarini, et al.Frontiers in Cardiovascular Medicine|July 5, 2021
Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) SurveyMaria Laura Canale, Fabio Turazza, Chiara Lestuzzi, et al.International Journal of Cardiology|February 8, 2011
Updated evidence on early statin therapy for acute coronary syndromes: meta-analysis of 18 randomized trials involving over 14,000 patientsMatthias Briel, Noah Vale, Gregory G Schwartz, et al.Giornale Italiano Di Cardiologia (2006)|March 27, 2023
[ANMCO Position paper: Vericiguat use in heart failure: from evidence to place in therapy]Stefania Angela Di Fusco, Alessandro Alonzo, Alberto Aimo, et al.European Heart Journal Supplements : Journal of the European Society of Cardiology|May 22, 2023
ANMCO position paper: guide to the appropriate use of the wearable cardioverter defibrillator in clinical practice for patients at high transient risk of sudden cardiac deathGiancarlo Casolo, Michele Massimo Gulizia, Daniela Aschieri, et al.European Heart Journal Supplements : Journal of the European Society of Cardiology|May 19, 2025
ANMCO statement: semaglutide in the cardio-nephro-metabolic continuumLeonardo De Luca, Claudio Bilato, Alessandro Navazio, et al.Pageof 45